Britain's FTSE lifted by deals and buzz in pharmaceuticals sector
Published on Apr 23, 2014 12:25 AM
LONDON (REUTERS) - Corporate activity in the pharmaceutical sector on Tuesday pushed Britain's benchmark stock index to a two-week high and to within sight of a peak for this year.
Drugmaker AstraZeneca rose 4.7 per cent, with trading volumes in the stock more than three times its 90-day average, after the Sunday Times reported a 60-billion-pound ($126.8 billion) approach from US peer Pfizer.
Both companies declined to comment. Analysts at Citigroup said in a research note they expected Pfizer "to push aggressively ahead with a second approach", referring to the reported rejection of the offer. Pfizer stock rose 1 per cent.
GlaxoSmithKline rose 5.2 per cent after an asset-swap with Swiss peer Novartis, which announced a multi-billion dollar revamp. Shire rose 7.6 per cent on hopes that sectoral takeover activity would spread.
To continue reading, log in if you are a subscriber
If you are not a subscriber, you can get instant, unlimited access here